Search Results - Richard E. Sutton

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    The role of the 3′-UTR of the chemokine receptor CCR2 and hnRNPA0 in regulating mRNA stability and subcellular distribution in human CD4+ T cells by Yunus Yukselten, Hanan Wishah, Lingyun Wang, Richard E. Sutton

    Published in Frontiers in Immunology (2025-08-01)
    Get full text
    Article


  2. 2

    High-level production of replication-defective human immunodeficiency type 1 virus vector particles using helper-dependent adenovirus vectors by Yani Hu, Kaitlin O'Boyle, Donna Palmer, Philip Ng, Richard E Sutton

    Get full text
    Article


  3. 3

    Correlation of a commercial platform's results with post-vaccination SARS-CoV-2 neutralizing antibody response and clinical host factors. by Rebecca Slotkin, Tassos C Kyriakides, Anupam Kundu, Gary Stack, Richard E Sutton, Shaili Gupta

    Published in PLoS ONE (2023-01-01)
    Get full text
    Article


  4. 4

    Multiple UBXN family members inhibit retrovirus and lentivirus production and canonical NFκΒ signaling by stabilizing IκBα. by Yani Hu, Kaitlin O'Boyle, Jim Auer, Sagar Raju, Fuping You, Penghua Wang, Erol Fikrig, Richard E Sutton

    Published in PLoS Pathogens (2017-02-01)
    Get full text
    Article


  5. 5

    UBXN1 Interferes with Rig-I-like Receptor-Mediated Antiviral Immune Response by Targeting MAVS by Penghua Wang, Long Yang, Gong Cheng, Guang Yang, Zhengyun Xu, Fuping You, Qiang Sun, Rongtuan Lin, Erol Fikrig, Richard E. Sutton

    Published in Cell Reports (2013-04-01)
    Get full text
    Article


  6. 6

    Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2. by Min Zhao, Pei-Yi Su, Danielle A Castro, Therese N Tripler, Yingxia Hu, Matthew Cook, Albert I Ko, Shelli F Farhadian, Benjamin Israelow, Charles S Dela Cruz, Yong Xiong, Richard E Sutton, Yale IMPACT Research Team

    Published in PLoS Pathogens (2021-06-01)
    Get full text
    Article


  7. 7

    The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication In Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters by Iart Luca Shytaj, Mohamed Fares, Lara Gallucci, Bojana Lucic, Mahmoud M. Tolba, Liv Zimmermann, Julia M. Adler, Na Xing, Judith Bushe, Achim D. Gruber, Ina Ambiel, Ahmed Taha Ayoub, Mirko Cortese, Christopher J. Neufeldt, Bettina Stolp, Mohamed Hossam Sobhy, Moustafa Fathy, Min Zhao, Vibor Laketa, Ricardo Sobhie Diaz, Richard E. Sutton, Petr Chlanda, Steeve Boulant, Ralf Bartenschlager, Megan L. Stanifer, Oliver T. Fackler, Jakob Trimpert, Andrea Savarino, Marina Lusic

    Published in mBio (2022-04-01)
    Get full text
    Article


Search Tools: